Looking for help with today's New York Times Wordle? Here are some expert hints, clues and commentary to help you solve today ...
Edison was sold on the one simple trick of falling into N1, the short, half-conscious sleep stage that marks the transition ...
Despite a challenging CASGEVY launch, high cash burn, and an almost 10% YTD share count growth, CRISPR’s pipeline breadth and ...
Like his previous two novels and short stories, Bryan Washington’s fourth book, “Palaver,” is set in Houston, where he’s from, and/or Japan, where he now lives. But in “Palaver,” which was nominated ...
Across Asia, a new storytelling phenomenon has reshaped the way audiences watch and connect. The short-form drama model, which is comprised of ultra-short, serialized dramas designed for vertical ...
Vertex Pharmaceuticals (NASDAQ:VRTX) has outperformed the market over the past 15 years by 5.91% on an annualized basis producing an average annual return of 18.0%. Currently, Vertex Pharmaceuticals ...
The FDA has slammed generic drug maker Hetero Labs with a Form 483 after an inspection of one of its warehouses in India uncovered flying birds, skittering lizards and roaming cats, among a host of ...
Advocacy groups form a buyer’s club to obtain generic versions of pricey Vertex cystic fibrosis drug
Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...
Vertex Pharmaceuticals has a lot of buy and hold ratings, but there aren't any sell ratings from Wall Street analysts. Around 75,000 people with cystic fibrosis rely on Vertex Pharmaceuticals to keep ...
The “Finding Your Arc” writing seminar for undergraduate students at the University of South Florida not only addresses how to write application essays for national scholarships and other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback